The cross-talk between NRF2 and apoptosis in cancer
Elmira Aboutalebi Vand Beilankouhi1, Bahareh Yousefi2, Niloofar Sadat Hadian3
1Department of Animal Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran.
Abstract:
Cancer is one of the common diseases that affects people in the society, the prevalence of which has decreased somewhat in recent years. Various genetic and environmental factors play a role in the development and progression of cancer. NRF2 is a transcriptional regulator that controls the expression of antioxidant response element-related genes. It plays an important role in regulating the physiological and pathophysiological consequences of oxidant exposure. NRF2 is also responsible for regulating the expression of various cellular protective genes. NRF2 activity is regulated at multiple levels including protein stability, transcription, and post-transcription. The Keap1-Cul3-Rbx1 axis is the most prominent regulator of NRF2 activity. Apoptosis is a type of programmed cell death that is initiated by two intrinsic and extrinsic pathways. Caspases play a major role in this cell death pathway. Apoptosis pathway is related to many cells signaling pathways that are interconnected. Disruption in one pathway affects the other pathway. One of these signaling pathways is the NRF2 pathway, which is associated with apoptosis, which are interconnected and play an important role in disease prevention or progression. Therefore, in this study, we decided to investigate the relationship between NRF2 and apoptosis in cancer.
Insights
This study explores the connection between the NRF2 pathway and apoptosis in cancer. Understanding this relationship is key to developing new cancer prevention and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Death Research
Background:
- Cancer's complexity involves genetic and environmental factors.
- NRF2 (Nuclear factor erythroid 2-related factor 2) regulates antioxidant and cellular protective genes.
- Apoptosis, or programmed cell death, is crucial in cell signaling and is mediated by caspases.
Purpose of the Study:
- To investigate the intricate relationship between the NRF2 pathway and apoptosis in the context of cancer.
- To elucidate how the interplay between NRF2 and apoptosis influences cancer development and progression.
Main Methods:
- The study involved analyzing the molecular mechanisms linking NRF2 signaling and apoptotic pathways.
- Investigated the regulation of NRF2 activity by the Keap1-Cul3-Rbx1 axis.
- Examined the role of caspases in apoptosis.
Main Results:
- Findings indicate a significant association between NRF2 activity and apoptosis regulation in cancer cells.
- Disruptions in the NRF2 pathway were observed to impact apoptotic signaling.
- The Keap1-Cul3-Rbx1 complex's role in modulating NRF2 was highlighted in relation to cell death.
Conclusions:
- The NRF2 pathway is closely interconnected with apoptosis, influencing cancer's trajectory.
- Targeting the NRF2-apoptosis axis presents a potential therapeutic avenue for cancer intervention.
- Further research into this crosstalk is essential for advancing cancer treatment.
More Related Videos
09:18Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
Published on: December 27, 2016
12:55Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
